COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 108 participants.
Also called NCT02744677
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 108 participants
- Sponsor
- Registry
-
NCT02744677
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT02744677. Non-randomized; no masking; primary purpose treatment. Start 2016-07-05 (actual); primary completion 2026-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
- Condition
- Complex Congenital Heart Defect
- Condition
- Dysfunctional RVOT Conduit
- Condition
- Pulmonary Valve Insufficiency
- Condition
- Pulmonary Valve Degeneration
- Intervention (Device)
- SAPIEN 3/SAPIEN 3 Ultra RESILIA THV
- Intervention (Device)
- SAPIEN 3 THV
- Intervention (Device)
- SAPIEN 3 Ultra RESILIA THV
- Lead sponsor
- Edwards Lifesciences
Record details
- Record id
cardio:ct-nct02744677- Content hash
64ed655104e3d66235ba6f9c89c070d58a6834ca1e764229c22ca00d5faf7f4b